close

African American(H)

African American(H)

Prenate® Vitamin Family Boosts Tolerance and Compliance with Prenatal Vitamin Formulas, Uniquely Designed to Address Specific Needs and Stages of Pregnancy, from Preconception through Post-Partum

Prenate_Logo-96918a846902a04ba46d40ceafefa0c5d36e5ac6

Prenate® VitaminATLANTA, June 14, 2017 /PRNewswire/ — Avion Pharmaceuticals®, a specialty pharmaceutical company providing innovative pharmaceutical and dietary supplement products, focused on women’s health and dermatology, recognizes the important role prenatal vitamins play in a healthy…

read more
African American(H)

California Cannabis Industry Association and National Cannabis Industry Association Launch California Cannabis Business Conference – Sept. 21-22 – Anaheim

NCIA_Logo-95a01d74a562ad45c4a8b64bba81928308385942

National Cannabis Industry AssociationANAHEIM, Calif., June 14, 2017 /PRNewswire/ — The California Cannabis Industry Association (CCIA), California’s leading industry association, and the National Cannabis Industry Association (NCIA), the only national trade association representing the legal marijuana industry, announce the…

read more
African American(H)

Achelios Therapeutics Concludes Successful Type C Meeting with FDA Regarding Its Lead Product, TOPOFEN™, for Prevention and Treatment of Migraine

no thumb

CHAPEL HILL, N.C., June 14, 2017 /PRNewswire/ — Achelios Therapeutics, a privately held pharmaceutical development company focused on innovative topical drug delivery technologies, announced today it has completed a Type C meeting with the FDA regarding a path to approval for TOPOFEN™ in…

read more
African American(H)

Helsinn Group and MEI Pharma Announce First Patient Dosed in Phase 2 Dose-Optimization Study of Pracinostat and Azacitidine in Myelodysplastic Syndrome

LUGANO, Switzerland and SAN DIEGO, June 14, 2017 /PRNewswire/ — Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today…

read more